Innova Captab Ltd - 544067 - Closure of Trading Window
The Trading window shall be closed from 1st July, 2024 till 48 hours of after the declaration of Unaudited Financial Results of the Company for the first quarter ended June 30, 2024.28-06-2024
28-06-2024
Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of the Investor/Analyst Earnings Call held on Thursday, May 30, 202405-06-2024
Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') - Audio Recording of Earnings Call:30-05-2024
Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of copy of Newspaper Advertisement dated 30th May 2024 pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015.30-05-2024
Innova Captab Results Earnings Call for Q4FY24
Conference Call with Innova Captab Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.30-05-2024
Q4FY24 Quarterly & FY24 Annual Result Announced for Innova Captab Ltd.
Pharmaceuticals company Innova Captab announced Q4FY24 & FY24 results: Q4FY24 Financial Highlights: Revenue from operation is Rs 262.63 crore in Q4FY24 as against Rs 240.95 crore of previous year registering a growth of 9.0%. The Company’s EBITDA stood at Rs 43.76 crore in Q4FY24 against Rs 29.42 crore of previous year registering a growth of 48.7%. Profit After Tax (PAT) stood at Rs 28.72 crore in Q4FY24 against Rs 17.25 crore of previous year registering a growth of 66.5%. FY24 Financial Highlights: Total Income for the FY24 stood at Rs 1,093.79 crore against Rs 935.58 crore in FY23 with growth of 16.9% over FY23. Revenue from Operation has increased to Rs 1,081.31 crore in FY24 from Rs 926.38 crore in FY23, registering a growth of 16.7%. The Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) stands at Rs 166.94 crore in FY24, as against Rs 122.85 crore in FY23, with an increase of 35.9%. Profit After Tax (PAT) is Rs 94.35 crore in FY24 as against Rs 67.95 crore in FY23, registering a growth of 38.9%. Earnings per share (EPS) for FY24 is Rs 18.66, against Rs 14.16 in FY23 For FY24, net cash generated from operating activities stood at Rs 146 crore, against Rs 67 crore in FY23. Commenting on the results, Vinay Lohariwala, Managing Director, - Innova Captab Limited said, For FY24, we reported a total income of Rs 1,094 crore with a growth of 16.9% compared to the previous year. Our all business areas are getting good traction and are expected to grow at a healthy rate in the coming years. Over the last 3-4 years, we have grown at a healthy rate of ~ 20% CAGR. With our upcoming Jammu facility and recent Sharon acquisition, we are positively looking forward to maintaining the same healthy growth rate over the next 3-4 years. As a company we continue to drive sustainable growth by exploring new opportunities and focusing on value-added products. Indian pharmaceutical companies are set to experience significant growth in the mid to long term, as both domestic and global manufacturers seek reliable and sustainable suppliers like us. Result PDF30-05-2024
Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for quarter and year ended March 31 202430-05-2024
Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Investor Presentation
intimation of investor call/earning call schedule to be held on Thursday,29th May 2024 at 12.00PM29-05-2024
Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcement under Regulation 30 (LODR)-Press Release/Media Release29-05-2024
Innova Captab Ltd - 544067 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcement under Regulation 30 (LODR)-Press Release/Media Release29-05-2024